Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove Phillip Papadimitri July 15 2026 Newsletter
A Congress Full of Connection, Innovation and Perspective Phillip Papadimitri July 15 2026 Newsletter
EU TAVI Market 2026: Growth, Competition, and the Rise of New Challengers Paul White July 10 2026 Newsletter
Ahead of SRS 2026: Surgical Robotics & AI, What Happens After Approval? Liam Newton June 26 2026 Newsletter
